Advertisement

Topics

Dr. Oestreich + Partner GmbH Company Profile

11:40 EST 17th December 2018 | BioPortfolio

Dr. Oestreich + Partner is an international full-service CRO which has also developed an EDC-System (Electronic Data Capture) for clinical trials called OPVerdi.
Following many years as clinical and research colleagues at universities, and after working together in marketing and development at pharmaceutical companies in Germany, England and the USA, Wolfgang Oestreich, M.D. and Brian Stuart Raftery founded Dr. Oestreich + Partner in Cologne, Germany, in 1991.
In order to offer individual as well as generalizes solutions, we have established subsidiaries which cater to other branches of the industry. These include manufacturers of pharmaceutical products, diagnostic equipment, medical technology, cosmetics, food and non-food items, and consumer products

Location

Research + Marketing in Medicine + PharmacyHansaring 102 - 104
Cologne
50670
Germany

Contact

Phone: 49 (0) 221 / 91 28 71-0
Fax: 49 (0) 221 / 91 28 71-1
Email: OPinfo@OandP-CRO.com


News Articles [418 Associated News Articles listed on BioPortfolio]

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Sandoz International GmbH Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

Sandoz International GmbH Strategy, SWOT and Corporate Finance ReportSummarySandoz International GmbH Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and infor...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Laufende Fusionskontrollverfahren: Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);

Datum der Anmeldung:28.08.2018Aktenzeichen:B3-128/18Unternehmen:Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);Produktmärkte:in.....

Laufende Fusionskontrollverfahren: The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB Innere Medizin GmbH & Co. KG, Monheim (D) und die UCB Primary Care GmbH, Monheim (D);

Datum der Anmeldung:07.08.2018Aktenzeichen:B3-119/18Unternehmen:The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB In....

Genmab and Immatics Partner on Next-Generation T-Cell Bispecific Immunotherapies Program

Denmark-based Genmab A/S struck a discovery and development deal with Immatics Biotechnologies GmbH.

Researcher wins $2 million NIH grant to study immunological memory

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a $2 million, five-year grant to Ken Oestreich, an assistant professor at the Virginia...

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

PubMed Articles [291 Associated PubMed Articles listed on BioPortfolio]

Chlamydia: a pill for the partner? Results of the PICC-UP project on patient-initiated partner therapy.

Effective partner notification and partner treatment are essential to prevent reinfection with Chlamydia trachomatis. For this reason we investigated the possibilities for patient-initiated partner th...

Perceived partner responsiveness predicts smoking cessation in single-smoker couples.

Romantic partners are crucial to successful smoking cessation, but the mechanisms by which partners influence cessation is unclear. Research in this area has focused heavily on partner smoking status ...

Characterizing Sexual Agreements With One's Most Recent Sexual Partner Among Young Men Who Have Sex With Men.

Men who have sex with men (MSM) often create sexual agreements with their partners, but little is known about agreements with serious versus causal partners. We used data from 472 young MSM to examine...

Leveraging Phylogenetics to Understand HIV Transmission and Partner Notification Networks.

Partner notification is an important component of public health test and treat interventions. To enhance this essential function, we assessed the potential for molecular methods to supplement routine ...

Intimate partner violence victimization increases the risk of under-five morbidity: A stratified multilevel analysis of pooled Tanzania Demographic Health Surveys, 2010-2016.

A hidden determinant such as intimate partner violence victimization has been associated with under-five morbidity and mortality. However, there is lack of information regarding which exactly age grou...

Clinical Trials [349 Associated Clinical Trials listed on BioPortfolio]

Study to Improve Partner Services for STD Prevention

The goal of this study was to examine the efficacy of patient-delivered partner treatment (PDPT) compared to standard partner referral (PR) and booklet enhanced partner referral (BEPR).

Control of Trichomoniasis

This study is designed to try to find the best method of partner notification and treatment for partners of women with trichomonas

Primary Prevention of Intimate Partner Violence in India

The goal of this study is to test and evaluate the feasibility, acceptance, safety, and efficacy of an an intimate partner violence (IPV) intervention in recently-married, low-income husba...

Brief Intervention to Reduce Drinking and Intimate Partner Violence in Women

The purpose of this study is to examine whether adding a brief alcohol treatment to standard violence intervention programs for women will result in reduced drinking, reduced partner viole...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Companies [1318 Associated Companies listed on BioPortfolio]

Dr. Oestreich + Partner GmbH

Dr. Oestreich + Partner is an international full-service CRO which has also developed an EDC-System (Electronic Data Capture) for clinical trials called OPVerdi. Following many years as clinical and r...

K+S KALI GmbH

K+S KALI GmbH is your world-wide partner in potash and magnesium products which find their uses in agriculture and industry.On this homepage the K+S KALI GmbH would like to introduce to you its wide r...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Kraeber GmbH & Co

Mein European producer of animal blood fractions from 18 spezies.Enzymatic process developments and productions by the daughter company Biot-ex GmbH and the cooperation partner Dr. Rieks GmbH.Fraction...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

More Information about "Dr. Oestreich + Partner GmbH" on BioPortfolio

We have published hundreds of Dr. Oestreich + Partner GmbH news stories on BioPortfolio along with dozens of Dr. Oestreich + Partner GmbH Clinical Trials and PubMed Articles about Dr. Oestreich + Partner GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dr. Oestreich + Partner GmbH Companies in our database. You can also find out about relevant Dr. Oestreich + Partner GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...


Corporate Database Quicklinks



Searches Linking to this Company Record